EUVIMEDEUVIMED entdecken
Crossref

Neuroprotective effects of combination of ezetimibe and sericin against lead-induced neurotoxicity

Pooja Temgire, Umashanker Navik, Puneet Kumar

Naunyn-Schmiedeberg's Archives of Pharmacology · 12.11.2026

DOI: 10.1007/s00210-026-06051-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 12.11.2026. Verfasst von Pooja Temgire und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic exposure to environmental pollutants, particularly heavy metals, has become a global health concern, reducing longevity. Among these, lead (Pb2+) is associated with neurobehavioral, neurodevelopmental, and neuropsychological impairments. Consequently, growing interest focuses on pharmacological and natural agents that restore neurotrophic signaling. Therefore, this study investigates neuroprotective effect of ezetimibe, an anti-hyperlipidemic agent, and sericin, a natural protein, in Pb2+-induced neurotoxicity in rats. Adult Wistar rats were divided into seven groups: control, lead acetate (PbAc2; 50 mg/kg), ezetimibe (10 and 20 mg/kg), sericin (200 and 400 mg/kg), and a combination of ezetimibe (10 mg/kg) and sericin (200 mg/kg) with PbAc2. PbAc2 was administered for 55 days, while ezetimibe and sericin treatment was initiated on days 29-55. Behavioral assessments, including grip strength, open field test, and Morris water maze test, were performed. On day 56, animals were sacrificed, and hippocampal tissues were collected for neurochemical (GABA, GAD1, and dopamine) and mitochondrial complex 3 estimation, along with hippocampal histology. The qRT-PCR (Bax, Bcl2, caspase - 3, CREB, BDNF), western blot (IGF-1R, GLP-1R, PI3K, pAkt) were performed. The results demonstrated that PbAc2 exposure induced behavioral deficits, neurotransmitter imbalance, disrupted mitochondrial-associated apoptotic pathway, and impaired neurotrophin signaling. Contrarily, ezetimibe and sericin, individually and in combination, significantly attenuated neurobehavioral impairments, restored neurochemical levels, improved mitochondrial complex III activity, suppressed apoptotic signaling, and preserved hippocampal histoarchitecture and enhanced synaptic plasticity through involvement of IGF-1R/GLP-1R signaling pathway. These findings suggest that ezetimibe and sericin, in combination, represent promising therapeutic candidates for mitigating PbAc2-induced neurotoxicity.

Schlagwörter

Stichwörter der Autor:innen

Cognitive impairmentEzetimibeGlucagon-like peptide 1Insulin-like growth factor-1Lead neurotoxicitySericin

Autor:innen und Institutionen

  • Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India.
  • Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India. punnubansal79@gmail.com.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Temgire, P., Navik, U., & Kumar, P. (2026). Neuroprotective effects of combination of ezetimibe and sericin against lead-induced neurotoxicity. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06051-9

Vancouver

Temgire P, Navik U, Kumar P. Neuroprotective effects of combination of ezetimibe and sericin against lead-induced neurotoxicity. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-06051-9

BibTeX
@article{Temgire2026,
  author = {Temgire, Pooja and Navik, Umashanker and Kumar, Puneet},
  title = {Neuroprotective effects of combination of ezetimibe and sericin against lead-induced neurotoxicity},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-06051-9}
}
Kostenlos starten →